In recent years, the use of nanotechnology in chemistry and drug manufacturing has become widespread in the medical field. Especially in combating organisms smaller than 100 nanometers, such as viruses, the effectiveness of large molecules is limited. To break down the surface envelope of a virus, drug particles smaller than 100 nanometers are needed. This allows for more effective targeting of the tissue and achieves effect with a smaller amount of drug. In other words, a lower dose ensures safety. At the same time, nanoparticles designed to accelerate absorption in cells enter the cell much more easily. Similarly, nanotechnological products are used to increase absorption through the skin. With the nanotechnology we have developed, we have produced nanomolecules of various sizes ranging from 16 nanometers to 340 nanometers. The effectiveness of these nanomolecules is greater than that of other large-molecule products.
Liposomal technology, particularly its use as a delivery system, facilitates the storage and transport of drugs across the cell membrane into the cell. It can be used to transport chemical substances that are normally harmful across the cell membrane into the cell. For example, cancer drugs that are harmful to the cell membrane and can damage the cell can be introduced into the cell using liposomes. The liposomes we have created are in the 340-450 nanometer range and have slow-release properties. It is possible to transport even smaller nanomolecules into the cell using these liposomes. These effects make them suitable for use in the pharmaceutical industry, as well as in disinfectants, the chemical industry, and in the coating of fabrics. Currently, large-molecule liposomes (1-2 microns) are used in existing technologies. Our liposomes are much more effective, have a higher antibacterial and antiviral capacity, and offer numerous absorption advantages in cosmetics.